世界の希少性ヘマトロジー治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Rare Hematology Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5982
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、希少性ヘマトロジー治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血漿由来因子、組換え因子）、用途別市場規模（血友病A、血友病B、フォンウィルブランド病、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・希少性ヘマトロジー治療の市場動向
・企業の競争状況、市場シェア
・希少性ヘマトロジー治療の種類別市場規模と予測2016-2027（血漿由来因子、組換え因子）
・希少性ヘマトロジー治療の用途別市場規模と予測2016-2027（血友病A、血友病B、フォンウィルブランド病、その他）
・希少性ヘマトロジー治療の北米市場規模2016-2027（アメリカ、カナダ）
・希少性ヘマトロジー治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・希少性ヘマトロジー治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・希少性ヘマトロジー治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・希少性ヘマトロジー治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Takeda、Biogen、Novo Nordisk、Bayer、CSL Behring、Pfizer、PRA Health Sciences、Celgene、Alexion Pharma、Amgen）
・結論

Growing prevalence of various blood diseases such as anemia, myeloma, leukemia and sickle cell anemia has led the hematologists to focus on various detection processes. As demand for comparatively conducting comparatively short diagnosis process is becoming the need of the hour, hematologists are looking for better treatment processes through accurate diagnosis process.

Market Analysis and Insights: Global Rare Hematology Treatment Market
The global Rare Hematology Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rare Hematology Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rare Hematology Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rare Hematology Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rare Hematology Treatment market.

Global Rare Hematology Treatment Scope and Market Size
Rare Hematology Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rare Hematology Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Plasma Derived Factors
Recombinant Factors

Segment by Application
Hemophilia A
Hemophilia B
Von Wilebrand Disease
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda
Biogen
Novo Nordisk
Bayer
CSL Behring
Pfizer
PRA Health Sciences
Celgene
Alexion Pharma
Amgen

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Hematology Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Plasma Derived Factors
1.2.3 Recombinant Factors
1.3 Market by Application
1.3.1 Global Rare Hematology Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hemophilia A
1.3.3 Hemophilia B
1.3.4 Von Wilebrand Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rare Hematology Treatment Market Perspective (2016-2027)
2.2 Rare Hematology Treatment Growth Trends by Regions
2.2.1 Rare Hematology Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rare Hematology Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Rare Hematology Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Rare Hematology Treatment Industry Dynamic
2.3.1 Rare Hematology Treatment Market Trends
2.3.2 Rare Hematology Treatment Market Drivers
2.3.3 Rare Hematology Treatment Market Challenges
2.3.4 Rare Hematology Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rare Hematology Treatment Players by Revenue
3.1.1 Global Top Rare Hematology Treatment Players by Revenue (2016-2021)
3.1.2 Global Rare Hematology Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Rare Hematology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rare Hematology Treatment Revenue
3.4 Global Rare Hematology Treatment Market Concentration Ratio
3.4.1 Global Rare Hematology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Hematology Treatment Revenue in 2020
3.5 Rare Hematology Treatment Key Players Head office and Area Served
3.6 Key Players Rare Hematology Treatment Product Solution and Service
3.7 Date of Enter into Rare Hematology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Hematology Treatment Breakdown Data by Type
4.1 Global Rare Hematology Treatment Historic Market Size by Type (2016-2021)
4.2 Global Rare Hematology Treatment Forecasted Market Size by Type (2022-2027)

5 Rare Hematology Treatment Breakdown Data by Application
5.1 Global Rare Hematology Treatment Historic Market Size by Application (2016-2021)
5.2 Global Rare Hematology Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rare Hematology Treatment Market Size (2016-2027)
6.2 North America Rare Hematology Treatment Market Size by Type
6.2.1 North America Rare Hematology Treatment Market Size by Type (2016-2021)
6.2.2 North America Rare Hematology Treatment Market Size by Type (2022-2027)
6.2.3 North America Rare Hematology Treatment Market Size by Type (2016-2027)
6.3 North America Rare Hematology Treatment Market Size by Application
6.3.1 North America Rare Hematology Treatment Market Size by Application (2016-2021)
6.3.2 North America Rare Hematology Treatment Market Size by Application (2022-2027)
6.3.3 North America Rare Hematology Treatment Market Size by Application (2016-2027)
6.4 North America Rare Hematology Treatment Market Size by Country
6.4.1 North America Rare Hematology Treatment Market Size by Country (2016-2021)
6.4.2 North America Rare Hematology Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Rare Hematology Treatment Market Size (2016-2027)
7.2 Europe Rare Hematology Treatment Market Size by Type
7.2.1 Europe Rare Hematology Treatment Market Size by Type (2016-2021)
7.2.2 Europe Rare Hematology Treatment Market Size by Type (2022-2027)
7.2.3 Europe Rare Hematology Treatment Market Size by Type (2016-2027)
7.3 Europe Rare Hematology Treatment Market Size by Application
7.3.1 Europe Rare Hematology Treatment Market Size by Application (2016-2021)
7.3.2 Europe Rare Hematology Treatment Market Size by Application (2022-2027)
7.3.3 Europe Rare Hematology Treatment Market Size by Application (2016-2027)
7.4 Europe Rare Hematology Treatment Market Size by Country
7.4.1 Europe Rare Hematology Treatment Market Size by Country (2016-2021)
7.4.2 Europe Rare Hematology Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rare Hematology Treatment Market Size (2016-2027)
8.2 Asia-Pacific Rare Hematology Treatment Market Size by Type
8.2.1 Asia-Pacific Rare Hematology Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rare Hematology Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rare Hematology Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Rare Hematology Treatment Market Size by Application
8.3.1 Asia-Pacific Rare Hematology Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rare Hematology Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rare Hematology Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Rare Hematology Treatment Market Size by Region
8.4.1 Asia-Pacific Rare Hematology Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rare Hematology Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rare Hematology Treatment Market Size (2016-2027)
9.2 Latin America Rare Hematology Treatment Market Size by Type
9.2.1 Latin America Rare Hematology Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Rare Hematology Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Rare Hematology Treatment Market Size by Type (2016-2027)
9.3 Latin America Rare Hematology Treatment Market Size by Application
9.3.1 Latin America Rare Hematology Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Rare Hematology Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Rare Hematology Treatment Market Size by Application (2016-2027)
9.4 Latin America Rare Hematology Treatment Market Size by Country
9.4.1 Latin America Rare Hematology Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Rare Hematology Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rare Hematology Treatment Market Size (2016-2027)
10.2 Middle East & Africa Rare Hematology Treatment Market Size by Type
10.2.1 Middle East & Africa Rare Hematology Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rare Hematology Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rare Hematology Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Rare Hematology Treatment Market Size by Application
10.3.1 Middle East & Africa Rare Hematology Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rare Hematology Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rare Hematology Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Rare Hematology Treatment Market Size by Country
10.4.1 Middle East & Africa Rare Hematology Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rare Hematology Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Rare Hematology Treatment Introduction
11.1.4 Takeda Revenue in Rare Hematology Treatment Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Rare Hematology Treatment Introduction
11.2.4 Biogen Revenue in Rare Hematology Treatment Business (2016-2021)
11.2.5 Biogen Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Rare Hematology Treatment Introduction
11.3.4 Novo Nordisk Revenue in Rare Hematology Treatment Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Rare Hematology Treatment Introduction
11.4.4 Bayer Revenue in Rare Hematology Treatment Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 CSL Behring
11.5.1 CSL Behring Company Details
11.5.2 CSL Behring Business Overview
11.5.3 CSL Behring Rare Hematology Treatment Introduction
11.5.4 CSL Behring Revenue in Rare Hematology Treatment Business (2016-2021)
11.5.5 CSL Behring Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Rare Hematology Treatment Introduction
11.6.4 Pfizer Revenue in Rare Hematology Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 PRA Health Sciences
11.7.1 PRA Health Sciences Company Details
11.7.2 PRA Health Sciences Business Overview
11.7.3 PRA Health Sciences Rare Hematology Treatment Introduction
11.7.4 PRA Health Sciences Revenue in Rare Hematology Treatment Business (2016-2021)
11.7.5 PRA Health Sciences Recent Development
11.8 Celgene
11.8.1 Celgene Company Details
11.8.2 Celgene Business Overview
11.8.3 Celgene Rare Hematology Treatment Introduction
11.8.4 Celgene Revenue in Rare Hematology Treatment Business (2016-2021)
11.8.5 Celgene Recent Development
11.9 Alexion Pharma
11.9.1 Alexion Pharma Company Details
11.9.2 Alexion Pharma Business Overview
11.9.3 Alexion Pharma Rare Hematology Treatment Introduction
11.9.4 Alexion Pharma Revenue in Rare Hematology Treatment Business (2016-2021)
11.9.5 Alexion Pharma Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Rare Hematology Treatment Introduction
11.10.4 Amgen Revenue in Rare Hematology Treatment Business (2016-2021)
11.10.5 Amgen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rare Hematology Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Plasma Derived Factors
Table 3. Key Players of Recombinant Factors
Table 4. Global Rare Hematology Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Rare Hematology Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rare Hematology Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Rare Hematology Treatment Market Share by Regions (2016-2021)
Table 8. Global Rare Hematology Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Rare Hematology Treatment Market Share by Regions (2022-2027)
Table 10. Rare Hematology Treatment Market Trends
Table 11. Rare Hematology Treatment Market Drivers
Table 12. Rare Hematology Treatment Market Challenges
Table 13. Rare Hematology Treatment Market Restraints
Table 14. Global Rare Hematology Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Rare Hematology Treatment Market Share by Players (2016-2021)
Table 16. Global Top Rare Hematology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Hematology Treatment as of 2020)
Table 17. Ranking of Global Top Rare Hematology Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Rare Hematology Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rare Hematology Treatment Product Solution and Service
Table 21. Date of Enter into Rare Hematology Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Rare Hematology Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Rare Hematology Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Rare Hematology Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Rare Hematology Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Rare Hematology Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Rare Hematology Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Rare Hematology Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Rare Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Rare Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Rare Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Rare Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Rare Hematology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Rare Hematology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Rare Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Rare Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Rare Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Rare Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Rare Hematology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Rare Hematology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Rare Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Rare Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Rare Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Rare Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rare Hematology Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Rare Hematology Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Rare Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Rare Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Rare Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Rare Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Rare Hematology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Rare Hematology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Rare Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Rare Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Rare Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Rare Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rare Hematology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Rare Hematology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Rare Hematology Treatment Product
Table 64. Takeda Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Biogen Company Details
Table 67. Biogen Business Overview
Table 68. Biogen Rare Hematology Treatment Product
Table 69. Biogen Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 70. Biogen Recent Development
Table 71. Novo Nordisk Company Details
Table 72. Novo Nordisk Business Overview
Table 73. Novo Nordisk Rare Hematology Treatment Product
Table 74. Novo Nordisk Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 75. Novo Nordisk Recent Development
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Rare Hematology Treatment Product
Table 79. Bayer Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. CSL Behring Company Details
Table 82. CSL Behring Business Overview
Table 83. CSL Behring Rare Hematology Treatment Product
Table 84. CSL Behring Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 85. CSL Behring Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Rare Hematology Treatment Product
Table 89. Pfizer Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. PRA Health Sciences Company Details
Table 92. PRA Health Sciences Business Overview
Table 93. PRA Health Sciences Rare Hematology Treatment Product
Table 94. PRA Health Sciences Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 95. PRA Health Sciences Recent Development
Table 96. Celgene Company Details
Table 97. Celgene Business Overview
Table 98. Celgene Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 99. Celgene Recent Development
Table 100. Alexion Pharma Company Details
Table 101. Alexion Pharma Business Overview
Table 102. Alexion Pharma Rare Hematology Treatment Product
Table 103. Alexion Pharma Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 104. Alexion Pharma Recent Development
Table 105. Amgen Company Details
Table 106. Amgen Business Overview
Table 107. Amgen Rare Hematology Treatment Product
Table 108. Amgen Revenue in Rare Hematology Treatment Business (2016-2021) & (US$ Million)
Table 109. Amgen Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Hematology Treatment Market Share by Type: 2020 VS 2027
Figure 2. Plasma Derived Factors Features
Figure 3. Recombinant Factors Features
Figure 4. Global Rare Hematology Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hemophilia A Case Studies
Figure 6. Hemophilia B Case Studies
Figure 7. Von Wilebrand Disease Case Studies
Figure 8. Others Case Studies
Figure 9. Rare Hematology Treatment Report Years Considered
Figure 10. Global Rare Hematology Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Rare Hematology Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Rare Hematology Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Rare Hematology Treatment Market Share by Regions (2022-2027)
Figure 14. Global Rare Hematology Treatment Market Share by Players in 2020
Figure 15. Global Top Rare Hematology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Hematology Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Rare Hematology Treatment Revenue in 2020
Figure 17. Global Rare Hematology Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Rare Hematology Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Rare Hematology Treatment Market Share by Type (2016-2027)
Figure 21. North America Rare Hematology Treatment Market Share by Application (2016-2027)
Figure 22. North America Rare Hematology Treatment Market Share by Country (2016-2027)
Figure 23. United States Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Rare Hematology Treatment Market Share by Type (2016-2027)
Figure 27. Europe Rare Hematology Treatment Market Share by Application (2016-2027)
Figure 28. Europe Rare Hematology Treatment Market Share by Country (2016-2027)
Figure 29. Germany Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Rare Hematology Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Rare Hematology Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Rare Hematology Treatment Market Share by Region (2016-2027)
Figure 39. China Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Rare Hematology Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Rare Hematology Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Rare Hematology Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Rare Hematology Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Rare Hematology Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Rare Hematology Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Rare Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Takeda Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 59. Biogen Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 60. Novo Nordisk Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 61. Bayer Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 62. CSL Behring Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 64. PRA Health Sciences Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 65. Celgene Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 66. Alexion Pharma Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 67. Amgen Revenue Growth Rate in Rare Hematology Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5000 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、尿素サイクル異常症（UCD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アミノ酸式、フェニル酪酸、安息香酸ナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別...

世界の腎臓シスチン症治療市場規模・現状・予測（2021年-2027年）

Global Nephropathic Cystinosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4563 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、腎臓シスチン症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（システイン枯渇療法、対症療法、腎移植）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリ...

世界のパニック発作治療市場規模・現状・予測（2021年-2027年）

Global Panic Attack Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5928 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、パニック発作治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（選択的セロトニン再取り込み阻害薬（SSRI）、セロトニンノルエピネフリン再取り込み阻害薬（SNRI）、ベンゾジアゼピン（BZD））、用途...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の後天性血友病治療市場規模・現状・予測（2021年-2027年） Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. Market Analysis and Insights: Global Acquired Hemophilia Treatment Market The global Acquired Hemophilia Treatment market size is projected…
世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年） The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing ammonia from the bloodstream. Market Analysis and Insights: Global Urea Cycle Disorders (UCD) Treatment Market The global Urea Cycle Disorders (UCD) Tre…
血液分析装置のグローバル市場2021 Hematology analyzers are computerized, highly specialized machines that count the number of different types of red and white blood cells, blood platelets, hemoglobin, and hematocrit levels in a blood sample. Currently, the Hematology Analyzers industry concentration is relatively high, there are app…
世界の組換え血漿タンパク質市場規模・現状・予測（2021年-2027年） For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins--such as coagulation factors, anticoagulants, immunoglobulins, and albumin--essential to the treatment of serious congenital or acquired bleeding or immunological diseases…
世界の腎臓シスチン症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nephropathic Cystinosis Treatment Market The global Nephropathic Cystinosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…